The Business Times

Vaccines

International

One in six US parents rejecting standard vaccine schedule: poll

Drugmakers fall on report US to claim Covid shot killed kids
Consumer & Healthcare

Drugmakers fall on report US to claim Covid shot killed kids

If fully enacted, Florida would become the first US state to abandon school vaccine requirements, long credited with wiping out once-common childhood scourges such as measles, mumps, rubella, polio and hepatitis B.
International

Florida to scrap all vaccine mandates, West Coast states push back

One logical fallacy used by tricksters is the false claim that since vaccines aren’t 100% safe and effective, they must be useless.
Opinion & Features
THE BROAD VIEW

Why bad arguments sound convincing

Seqirus will list on the Australian securities exchange by the end of this fiscal year.
Consumer & Healthcare

Australian biotech giant CSL to spin off vaccine unit Seqirus, cut 15% of workforce

Aside from flu shots, Ab&B is also developing vaccines for rabies, herpes and other respiratory diseases, with plans to commercialise them in China and beyond.
Consumer & Healthcare

Chinese flu shot maker soars in Hong Kong trading debut

(FILES) A picture taken on February 4, 2022 shows a screen bearing the new logo of French pharmaceutical group Sanofi which is presented on the day of the group's 2021 full year results at Sanofi headquarters in Paris. French pharmaceutical giant Sanofi boosted its profits in 2024, a year that saw its flagship product Dupixent exceed its sales target and marked by the commercial success of its bronchiolitis preventative treatment Beyfortus on January 30, 2025. (Photo by Eric PIERMONT / AFP)
Companies & Markets

Sanofi to buy Vicebio for up to US$1.6 billion in vaccine push

Moderna has been under pressure to find new sources of revenue as its Covid vaccine sales fall sharply and it spends heavily on its pipeline.
Consumer & Healthcare

Trump team weighs pulling funds for Moderna bird flu vaccine

Merck can now integrate vaccine production within its own manufacturing network to supply global markets.
Consumer & Healthcare

China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million

FILE PHOTO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File Photo
Consumer & Healthcare

Sanofi profit lifted by early vaccine sales, Dupixent growth

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More